Recro Pharma Inc (NASDAQ:REPH)

7.38
Delayed Data
As of 3:00pm ET
 -0.21 / -2.77%
Today’s Change
2.36
Today|||52-Week Range
15.40
+158.04%
Year-to-Date
No recent news for Recro Pharma Inc.

Today’s Trading

Previous close7.59
Today’s open7.41
Day’s range7.17 - 7.66
Volume39,569
Average volume (3 months)156,184
Market cap$59.5M
Dividend yield--
Data as of 3:00pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)-697.14%
Earnings growth (this year)+24.19%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.09

Competitors

 Today’s
change
Today’s
% change
ONTXOnconova Therapeutic...+0.04+1.46%
EBIOEleven Biotherapeuti...-0.08-2.58%
JAGXJaguar Animal Health...-0.02-0.30%
NYMXNymox Pharmaceutical...+0.01+0.65%
Data as of 2:59pm ET, 05/22/2015

Financials

Last reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.53
Annual revenue (last year)$0.00
Annual profit (last year)-$16.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gerri A. Henwood
Treasurer, Chief Financial &
Business Officer
Charles T. Garner
Corporate headquarters
Malvern, Pennsylvania

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers